Transfusion Medicine Market: Supplier Shares by Country, Emerging Technologies, Strategic Profiles of Leading Suppliers
This 114-page report provides assessments of such technologies as molecular diagnostics, monoclonal and polyclonal antibodies, immunoassays, microtitration plates, IT, lasers, synthetic red cell substitutes, genetically engineered blood components, blood preservation, autologous blood transfusion/freezing and their potential applications for transfusion diagnostic. The report also presents strategic assessments of current and emerging suppliers of transfusion diagnostic products, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.
Contains 114 pages
Contains 114 pages
CURRENT AND EMERGING TECHNOLOGIES
MOLECULAR DIAGNOSTICS
a. Overview
b. NAT
MONOCLONAL AND POLYCLONAL ANTIBODIES
IMMUNOASSAYS
a. Technological Principle
b. Chemiluminescence
c. Enzyme Immunoassays (EIA)
Overview
ELISA
EMIT
Electrochemical
d. Radioimmunoassays (RIA)
e. Immunoprecipitation
f. Affinity Chromatography
MICROTITRATION PLATES
IT AND AUTOMATION
LASERS
ROBOTICS
SYNTHETIC RED CELL SUBSTITUTES
GENETICALLY ENGINEERED BLOOD COMPONENTS
a. Albumin
b. Factor VIII
c. Alpha-2 Antiplasmin
d. Antithrombin III
e. Factor IX
f. Von Willebrand's Factor
g. Fibrinogen
h. t-PA
BLOOD PRESERVATION
AUTOLOGOUS BLOOD TRANSFUSION/FREEZING
COMPETITIVE PROFILES
Abbott
Beckman Coulter/Danaher
Becton Dickinson
Biokit
BioMerieux
Bio-Rad
CellMark Forensics/LabCorp
Diagast
DiaSorin
Fujirebio
Grifols
Hologic/Gen-Probe
Immucor
Ortho-Clinical Diagnostics
Proteome Sciences
Quest Diagnostics
Roche
Siemens
Tecan
Thermo Fisher
MOLECULAR DIAGNOSTICS
a. Overview
b. NAT
MONOCLONAL AND POLYCLONAL ANTIBODIES
IMMUNOASSAYS
a. Technological Principle
b. Chemiluminescence
c. Enzyme Immunoassays (EIA)
Overview
ELISA
EMIT
Electrochemical
d. Radioimmunoassays (RIA)
e. Immunoprecipitation
f. Affinity Chromatography
MICROTITRATION PLATES
IT AND AUTOMATION
LASERS
ROBOTICS
SYNTHETIC RED CELL SUBSTITUTES
GENETICALLY ENGINEERED BLOOD COMPONENTS
a. Albumin
b. Factor VIII
c. Alpha-2 Antiplasmin
d. Antithrombin III
e. Factor IX
f. Von Willebrand's Factor
g. Fibrinogen
h. t-PA
BLOOD PRESERVATION
AUTOLOGOUS BLOOD TRANSFUSION/FREEZING
COMPETITIVE PROFILES
Abbott
Beckman Coulter/Danaher
Becton Dickinson
Biokit
BioMerieux
Bio-Rad
CellMark Forensics/LabCorp
Diagast
DiaSorin
Fujirebio
Grifols
Hologic/Gen-Probe
Immucor
Ortho-Clinical Diagnostics
Proteome Sciences
Quest Diagnostics
Roche
Siemens
Tecan
Thermo Fisher
More Publications
Shimadzu: 2019 Strategic Direction, Marketing Tactics, Technological Know-How in Medical Imaging
US$ 450.00
April 2019
-
2019-2023 Leading Diagnostic Imaging Companies: Technological Know-How and Global Sales Segment Forecasts
US$ 2,450.00
January 2019
60 pages
2016-2020 Future Horizons and Growth Strategies in the World X-Ray Equipment Market: Strategic Assessments of Leading Suppliers--M&A, Technological Capabilities, Marketing Tactics, Joint Ventures, Strategic Directions
US$ 5,920.00
March 2016
710 pages
Wright Medical: 2017-2021 Global Market Segment Forecasts and Company's Strategic Assessment
US$ 1,850.00
December 2017
30 pages
2016-2020 Future Horizons and Growth Strategies in the Global MRI Market: Strategic Assessments of Leading Suppliers
US$ 5,920.00
March 2016
548 pages